Summary of Significant Accounting Policies - Segments (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2022 USD ($) segment	Sep. 30, 2021 USD ($)
Medical Indication Information
Number of reportable segments | segment	1
Total net sales	$ 75,079	$ 101,525
Analgesic
Medical Indication Information
Total net sales	3,424	5,314
Anti-Psychosis
Medical Indication Information
Total net sales	2,620	3,715
Cardiovascular
Medical Indication Information
Total net sales	10,882	14,100
Central Nervous System
Medical Indication Information
Total net sales	20,794	22,785
Endocrinology
Medical Indication Information
Total net sales	7,312	7,845
Gastrointestinal
Medical Indication Information
Total net sales	7,942	15,240
Infectious Disease
Medical Indication Information
Total net sales	5,069	12,515
Migraine
Medical Indication Information
Total net sales	3,324	4,685
Respiratory/Allergy/Cough/Cold
Medical Indication Information
Total net sales	1,202	3,114
Other
Medical Indication Information
Total net sales	8,759	10,352
Contract manufacturing revenue
Medical Indication Information
Total net sales	$ 3,751	$ 1,860